Immune Checkpoint Inhibitor Associated Autoimmune Encephalitis, Rare and Novel Topic of Neuroimmunology: A Case Report and Review of the Literature

Immune checkpoint inhibitors (ICIs) are being used in patients with various advanced malignancies, and patient outcomes have improved considerably. Although ICIs can effectively treat tumors, 30–60% of patients experience immune-related adverse events (irAEs). Autoimmune encephalitis (AE) is a rare...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Yining, Pan, Jie, Shen, Dingding, Peng, Lisheng, Mao, Zhifeng, Wang, Chunxia, Meng, Huanyu, Zhou, Qinming, Chen, Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221042/
https://www.ncbi.nlm.nih.gov/pubmed/35741658
http://dx.doi.org/10.3390/brainsci12060773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221042/
https://www.ncbi.nlm.nih.gov/pubmed/35741658
http://dx.doi.org/10.3390/brainsci12060773

Ejemplares similares